NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Dawon Medax

Dawon Medax

Private
IncheonHealthcare & Life Scienceshttps://dawonmedax.com/

Last Round

Growth Equity

Feb 6, 2026

Total Funding Raised

$39.17M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Dawon Medax is a biotechnology company that develops boron neutron capture therapy (BNCT) systems and related radiopharmaceuticals for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

boron neutron capture therapyBNCTcancer treatmentradiation therapymedical acceleratortargeted cancer therapytreatment planning softwareTPSboron drugsoncology equipmentprecision medicineproton therapyparticle therapynext-gen radiotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dawon Medax Comparables

Compare Dawon Medax with similar companies based on industry and business-model similarity.

Dawon Medax comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TAE Life Sciences
89%
Neutron Therapeutics
89%
Neuboron Medical Group
87%

Dawon Medax Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityFeb 6, 2026
Series BSep 1, 2019
Series ADec 1, 2017

Key People

Founding team and executive leadership

Byung Guk Yang

Chief Executive Officer

Executive Team

Young-soon Bae

CTO

Executive Team

Dawon Medax Investors

Notable investors and investment history

Dawon Medax investors
InvestorRounds
SV InvestmentSeries A
KDB Capital CorpSeries A
Ministry of Trade, Industry and EnergyGrant
BNK VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 6, 2026

    Raised $29M in Growth Equity funding.

  • Dec 1, 2017

    $15M round with KDB Capital Corp and BNK Ventures.

Dawon Medax Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dawon Medax Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dawon Medax's valuation, stock price, and market status.

Firmographic Details

HeadquartersIncheon
Employee Range13
Year Founded2015
Last FundingFeb 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.